Lab-Grown mini tumors could someday guide pancreatic cancer treatment
NCT ID NCT05351983
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether it is safe and possible to grow mini-tumors (organoids) from pancreatic cancer samples in the lab. 60 patients with pancreatic cancer provided tumor tissue during surgery or biopsy. The goal was to see if these organoids could be used to test different chemotherapy drugs. The results did not change the treatment patients received, but the information gathered may help doctors choose better treatments in the future.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREAS ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hirslanden Kliniks
Zurich, Canton of Zurich, 8002, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can pancreatic Cancer's inflammatory footprint be stopped?
- Could a vaccine help fight Hard-to-Treat cancers?
- Blood and gut clues may flag pancreatic cancer risk early
- A high-tech camera may take the guesswork out of spotting a dangerous surgery complication
- Can a new imaging trick spot pancreatic cancer without a biopsy?
- MRI might reveal hidden pancreatic risks in obesity